## LYB: LyondellBasell Industries NV - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.7% in lower entry zone (3.0-6.0%), top 8% cross-sectional ranking. Short-term MRS_5 (1.4%) confirms momentum alignment. Strong momentum (+1.3% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($44.64)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Europe Propylene Glycol Market Size, Share and Trends, 2033**
- Source: Market Data Forecast | 20251130T125114 | Somewhat-Bullish | Relevance: 98%
- The Europe propylene glycol market was valued at USD 983.06 million in 2024 and is projected to reach USD 1,656.64 million by 2033, growing at a CAGR of 5.97%. Key drivers include rising demand from pharmaceuticals and bio-based personal care products, while challenges include stringent regulations and volatility in feedstock pricing. Opportunities lie in expanding renewable propylene glycol production and its adoption in aviation de-icing fluids.

**2. (LYB) as a Liquidity Pulse for Institutional Tactics**
- Source: Stock Traders Daily | 20251129T145000 | Neutral | Relevance: 98%
- This article provides an AI-driven analysis of Lyondellbasell Industries Nv Class A (NYSE: LYB), highlighting a strong near and mid-term sentiment despite a weak long-term outlook. It identifies a mid-channel oscillation pattern and an exceptional risk-reward short setup. The analysis also outlines three distinct institutional trading strategies: a position trading strategy, a momentum breakout strategy, and a risk-hedging strategy.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-19 | Citigroup | $43 | $47 | -9% |
| 2025-11-11 | Evercore ISI Gr | $57 | $65 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-19 | Citigroup | main | Neutral |
| 2025-11-11 | Evercore ISI Gr | main | In-Line |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.25M) |
| Sells | 7 ($0.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.1% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+0.3%)
- Blackrock Inc.: 9.0% (+12.4%)
- Dodge & Cox Inc.: 5.3% (-0.0%)
- State Street Corpora: 4.1% (+2.1%)
- Capital World Invest: 3.0% (+13.1%)

### Key Risks

1. Long-term trend broken: trading 16.7% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +1.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.85 indicates undervaluation relative to growth. Forward P/E 13.3x attractive for 42% earnings growth. Analyst sentiment negative (2 target cuts vs 0 raises).

| Metric | Value |
|--------|-------|
| Market Cap | $14.6B |
| Beta | 0.74 |
| 52W Range | $41.58 - $79.39 |
| Short Interest | 7.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.85 |
| Forward P/E | 13.3 |
| Current P/E | 18.8 |
| YoY Growth | 42.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 2.4% to 3.7% (+1.3% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 91st percentile. MRS_5 at 1.4% confirms short-term momentum alignment. Below SMA200 (0.83x), long-term trend not supportive. MACD histogram positive (0.74), confirming momentum. RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.71% (CS: 92) | Strong |
| RSI_14 | 57.7 | Neutral |
| MACD Histogram | 0.74 | Bullish |
| vs SMA20 | 1.070x | Above |
| vs SMA50 | 1.029x | Above |
| vs SMA200 | 0.833x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $47.92
- **Stop Loss:** $44.64 (6.8% risk)
- **Target:** $52.84 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 365
- **Position Value:** $17,490.80
- **Portfolio %:** 17.49%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-01-30 (Est: $0.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.80 | $1.01 | +25.9% |
| 2025Q2 | $0.78 | $0.62 | -20.8% |
| 2025Q1 | $0.43 | $0.33 | -24.0% |
| 2024Q4 | $0.70 | $0.75 | +6.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*